Global Information
회사소개 | 문의 | 위시리스트

세계의 혈액 스크리닝(혈액검사) 시장 예측(-2024년) : 핵산증폭, 실시간 PCR, 효소결합면역흡착검사(ELISA), 신속검사, 웨스턴 블롯

Blood Screening Market by Technology (Nucleic Acid Amplification, (Real Time PCR), ELISA (Chemiluminescence Immunoassay), Rapid Test, Western Blot), Product (Instrument, Reagent & Kits, Software) & End User - Global Forecast to 2024

리서치사 MarketsandMarkets
발행일 2019년 12월 상품 코드 326050
페이지 정보 영문 167 Pages
가격
US $ 4,950 ₩ 5,877,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 7,896,000 PDF by E-mail (5-user license) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 9,677,000 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 11,874,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 혈액 스크리닝(혈액검사) 시장 예측(-2024년) : 핵산증폭, 실시간 PCR, 효소결합면역흡착검사(ELISA), 신속검사, 웨스턴 블롯 Blood Screening Market by Technology (Nucleic Acid Amplification, (Real Time PCR), ELISA (Chemiluminescence Immunoassay), Rapid Test, Western Blot), Product (Instrument, Reagent & Kits, Software) & End User - Global Forecast to 2024
발행일 : 2019년 12월 페이지 정보 : 영문 167 Pages

혈액 스크리닝(혈액검사) 시장은 2019년 22억 달러에서 2024년까지 33억 달러까지 확대될 것으로 보입니다. 2019-2024년간 연평균 복합 성장률(CAGR)은 8.7%를 나타낼 전망입니다.

세계의 혈액 스크리닝(혈액검사) 시장에 대해 조사 분석했으며, 시장 개요, 산업 동향, 부문별 시장 분석, 경쟁 상황, 주요 기업 등에 대해 체계적인 정보를 제공합니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

  • 혈액 스크리닝(혈액검사) 시장 개요
  • 아시아태평양의 혈액 스크리닝(혈액검사) 시장 점유율 : 최종사용자별, 국가별
  • 혈액 스크리닝(혈액검사) 시장 : 제품·서비스별
  • 혈액 스크리닝(혈액검사) 시장의 지역별 현황

제5장 시장 개요

  • 서론
  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 해결해야 할 과제

제6장 세계의 혈액 스크리닝(혈액검사) 시장 : 제품 및 서비스별

  • 서론
  • 시약 및 키트
  • 계기
  • 소프트웨어 및 서비스

제7장 세계의 혈액 스크리닝(혈액검사) 시장 : 기술별

  • 서론
  • 핵산검사(NAT)
  • 효소결합면역흡착검사(ELISA)
  • 신속검사
  • 웨스턴 블롯
  • 차세대 시퀀싱(NGS)

제8장 세계의 혈액 스크리닝(혈액검사) 시장 : 최종사용자별

  • 서론
  • 혈액은행
  • 병원

제9장 세계의 혈액 스크리닝(혈액검사) 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제10장 경쟁 상황

  • 개요
  • 시장 점유율 분석
  • 경쟁 시나리오
  • 경쟁 리더십 매핑

제11장 기업 개요

  • GRIFOLS
  • F. HOFFMANN-LA ROCHE
  • ABBOTT LABORATORIES
  • BIOMERIEUX
  • BIO-RAD LABORATORIES
  • BECTON, DICKSON AND COMPANY
  • DANAHER CORPORATION
  • ORTHO CLINICAL DIAGNOSTICS
  • SIEMENS HEALTHINEERS
  • THERMO FISHER SCIENTIFIC
  • DIASORIN
  • GE HEALTHCARE
  • MERCK KGAA
  • PERKINELMER
  • BIO-TECHNE
  • GFE
  • TRINITY BIOTECH
  • J. MITRA DIAGNOSTICS PVT. LTD.

제12장 부록

LSH 19.12.17

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

LIST OF TABLES

  • TABLE 1 GLOBAL CANCER INCIDENCE, 2018 VS. 2025
  • TABLE 2 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 3 BLOOD SCREENING REAGENTS & KITS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 4 BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 5 NAT REAGENTS & KITS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6 NAT REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 7 ELISA REAGENTS & KITS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8 ELISA REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 9 OTHER REAGENTS & KITS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 10 BLOOD SCREENING INSTRUMENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11 BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 12 MARKET FOR RENTAL PURCHASE OF BLOOD SCREENING INSTRUMENTS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13 MARKET FOR OUTRIGHT PURCHASE OF BLOOD SCREENING INSTRUMENTS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14 BLOOD SCREENING SOFTWARE & SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15 BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 16 BLOOD SCREENING MARKET FOR NAT, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17 BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 18 TRANSCRIPTION-MEDIATED AMPLIFICATION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19 REAL-TIME PCR MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20 BLOOD SCREENING MARKET FOR ELISA, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 21 BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 22 CHEMILUMINESCENCE IMMUNOASSAYS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 23 FLUORESCENT IMMUNOASSAYS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24 COLORIMETRIC IMMUNOASSAYS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 25 BLOOD SCREENING MARKET FOR RAPID TESTS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26 BLOOD SCREENING MARKET FOR WESTERN BLOT ASSAYS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 27 BLOOD SCREENING MARKET FOR NGS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 28 BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 29 BLOOD SCREENING MARKET FOR BLOOD BANKS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 30 BLOOD SCREENING MARKET FOR HOSPITALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 31 BLOOD SCREENING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 32 NORTH AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 33 NORTH AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 34 NORTH AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 35 NORTH AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 36 NORTH AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 37 NORTH AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 38 NORTH AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 39 NORTH AMERICA: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 40 INCIDENCE OF VARIOUS CANCERS IN THE US, 2018 VS. 2025
  • TABLE 41 US: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 42 US: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 43 US: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 44 US: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 45 US: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 46 US: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 47 US: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 48 CANADA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 49 CANADA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 50 CANADA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 51 CANADA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 52 CANADA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 53 CANADA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 54 CANADA: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 55 EUROPE: BLOOD SCREENING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 56 EUROPE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 57 EUROPE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 58 EUROPE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 59 EUROPE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 60 EUROPE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 61 EUROPE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 62 EUROPE: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 63 GERMANY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 64 GERMANY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 65 GERMANY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 66 GERMANY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 67 GERMANY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 68 GERMANY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 69 GERMANY: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 70 FRANCE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 71 FRANCE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 72 FRANCE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 73 FRANCE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 74 FRANCE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 75 FRANCE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 76 FRANCE: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 77 UK: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 78 UK: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 79 UK: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 80 UK: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 81 UK: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 82 UK: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 83 UK: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 84 ITALY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 85 ITALY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 86 ITALY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 87 ITALY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 88 ITALY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 89 ITALY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 90 ITALY: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 91 SPAIN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 92 SPAIN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 93 SPAIN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 94 SPAIN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 95 SPAIN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 96 SPAIN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 97 SPAIN: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 98 ROE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 99 ROE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 100 ROE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 101 ROE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 102 ROE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 103 ROE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 104 ROE: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 105 ASIA PACIFIC: BLOOD SCREENING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 107 ASIA PACIFIC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 108 ASIA PACIFIC: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 109 ASIA PACIFIC: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 111 ASIA PACIFIC: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 113 CHINA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 114 CHINA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 115 CHINA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 116 CHINA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 117 CHINA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 118 CHINA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 119 CHINA: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 120 JAPAN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 121 JAPAN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 122 JAPAN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 123 JAPAN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 124 JAPAN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 125 JAPAN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 126 JAPAN: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 127 INDIA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 128 INDIA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 129 INDIA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 130 INDIA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 131 INDIA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 132 INDIA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 133 INDIA: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 134 AUSTRALIA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 135 AUSTRALIA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 136 AUSTRALIA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 137 AUSTRALIA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 138 AUSTRALIA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 139 AUSTRALIA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 140 AUSTRALIA: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 141 ROAPAC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 142 ROAPAC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 143 ROAPAC: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 144 ROAPAC: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 145 ROAPAC: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 146 ROAPAC: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 147 ROAPAC: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 148 LATIN AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 149 LATIN AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 150 LATIN AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 151 LATIN AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 152 LATIN AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 153 LATIN AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 154 LATIN AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 155 LATIN AMERICA: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 156 INCIDENCE OF VARIOUS CANCERS IN BRAZIL, 2018 VS. 2025
  • TABLE 157 BRAZIL: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 158 BRAZIL: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 159 BRAZIL: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 160 BRAZIL: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 161 BRAZIL: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 162 BRAZIL: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 163 BRAZIL: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 164 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 165 REST OF LATIN AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 166 REST OF LATIN AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 167 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 168 REST OF LATIN AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 169 REST OF LATIN AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 170 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 171 MEA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 172 MEA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 173 MEA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017-2024 (USD MILLION)
  • TABLE 174 MEA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 175 MEA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 176 MEA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 177 MEA: BLOOD SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 4 DATA TRIANGULATION METHODOLOGY
  • FIGURE 5 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD BILLION)
  • FIGURE 6 BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019 VS. 2024 (USD BILLION)
  • FIGURE 7 BLOOD SCREENING MARKET, BY END USER, 2019 VS. 2024 (USD BILLION)
  • FIGURE 8 GEOGRAPHIC OUTLOOK: BLOOD SCREENING MARKET
  • FIGURE 9 INCREASING PREVALENCE OF CHRONIC & INFECTIOUS DISEASES TO DRIVE MARKET GROWTH
  • FIGURE 10 BLOOD BANKS WERE THE LARGEST END USERS OF BLOOD SCREENING PRODUCTS AND SERVICES IN THE ASIA PACIFIC IN 2018
  • FIGURE 11 REAGENTS & KITS SEGMENT DOMINATES THE BLOOD SCREENING MARKET
  • FIGURE 12 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 13 RISE IN HIV-AFFECTED PATIENT POPULATION, 2000-2018
  • FIGURE 14 REAGENTS & KITS SEGMENT IS EXPECTED TO HOLD THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 15 NAT SEGMENT WILL CONTINUE TO DOMINATE THE BLOOD SCREENING MARKET IN 2024
  • FIGURE 16 BLOOD BANKS SEGMENT WILL CONTINUE TO DOMINATE THE BLOOD SCREENING MARKET DURING THE FORECAST PERIOD
  • FIGURE 17 NORTH AMERICA: BLOOD SCREENING MARKET SNAPSHOT
  • FIGURE 18 ASIA PACIFIC: BLOOD SCREENING MARKET SNAPSHOT
  • FIGURE 19 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2017 AND 2019
  • FIGURE 20 MARKET EVOLUTION FRAMEWORK
  • FIGURE 21 NAT BLOOD SCREENING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018
  • FIGURE 22 BLOOD SCREENING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018
  • FIGURE 23 COMPETITIVE LEADERSHIP MAPPING
  • FIGURE 24 GRIFOLS: COMPANY SNAPSHOT (2018)
  • FIGURE 25 F. HOFFMAN-LA ROCHE: COMPANY SNAPSHOT (2018)
  • FIGURE 26 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2018)
  • FIGURE 27 BIOMERIEUX: COMPANY SNAPSHOT (2018)
  • FIGURE 28 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2018)
  • FIGURE 29 BECTON, DICKSON AND COMPANY: COMPANY SNAPSHOT (2018)
  • FIGURE 30 DANAHER CORPORATION: COMPANY SNAPSHOT (2018)
  • FIGURE 31 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2018)
  • FIGURE 32 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2018)
  • FIGURE 33 DIASORIN: COMPANY SNAPSHOT (2018)
  • FIGURE 34 GENERAL ELECTRIC: COMPANY SNAPSHOT (2018)
  • FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2018)
  • FIGURE 36 PERKINELMER: COMPANY SNAPSHOT (2018)
  • FIGURE 37 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2018)

"Increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens are driving the overall growth of the blood screening market"

The blood screening market is projected to reach USD 3.3 billion by 2024 from USD 2.2 billion in 2019, at a CAGR of 8.7%. Growth in this market is driven by the increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens. Technological advancements and developing economies are expected to present opportunities for growth for players in the blood screening market. However, the need to reduce blood screening prices is a major factor in challenging market growth.

"Nucleic Acid Testing (NAT) segment accounted for the larger share of the blood screening market, by technology, in 2018"

The blood screening market, by technology, has been segmented into nucleic acid testing (NAT), enzyme-linked immunosorbent assays (ELISA), rapid tests, western blot assays, and next-generation sequencing (NGS). The NAT segment dominates the blood screening market, by technology, primarily due to the increasing number of blood donations and the increasing adoption of NAT technology due to its higher sensitivity over other blood screening technologies. Based on type, the blood screening market for NAT is segmented into transcription-mediated amplification (TMA) and real-time PCR. Among these, the TMA segment accounts for the larger market share due to the higher sensitivity of this assay.

"Blood banks to register the highest growth in the blood screening market during the forecast period"

Based on end users, the blood screening market is segmented into blood banks and hospitals. The blood bank segment accounted for the larger market share in 2018 and is projected to witness a higher growth rate during the forecast period. This can be attributed to the increasing demand for donated blood, a growing number of organ transplantation surgeries, rising awareness regarding the safety of blood, increasing the number of donations worldwide, and growth in government funding to charitable trusts.

"North America will continue to dominate the blood screening market during the forecast period"

Based on region, the blood screening market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2018, North America accounted for the largest market share, followed by Europe. Factors such as the increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens, the presence of high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the blood screening market in North America.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 36%, Tier 2 - 45%, and Tier 3 - 19%
  • By Designation: C-level - 33%, D-level - 40%, and Others - 27%
  • By Region: North America - 39%, Europe - 28%, Asia Pacific - 19%, Latin America- 9% and the Middle East and Africa- 5%

Companies Profiled in the Report:

Prominent players in the blood screening market include: Grifols (Spain), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (US), BioMerieux (France), Bio-Rad Laboratories (US), Siemens Healthineers (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US) ,Ortho Clinical Diagnostics, Inc. (US), Becton, Dickinson and Company (US), DiaSorin (Italy), GFE (Germany), Trinity Biotech (Ireland), Merck Millipore (Germany), GE Healthcare (US), Perkin Elmer (US), Bio-Techne Corporation (US), and J Mitra & Co. Pvt. Ltd (India).

Research Coverage:

This report provides a detailed picture of the global blood screening market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, technology, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall blood screening market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, challenges, opportunities, and trends.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH DESIGN
  • 2.3 SECONDARY DATA
    • 2.3.1 SECONDARY SOURCES
  • 2.4 PRIMARY DATA
    • 2.4.1 KEY DATA FROM PRIMARY SOURCES
  • 2.5 MARKET SIZE ESTIMATION
    • 2.5.1 BOTTOM-UP APPROACH
    • 2.5.2 TOP-DOWN APPROACH
    • 2.5.3 GROWTH FORECAST
  • 2.6 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.7 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 BLOOD SCREENING MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: BLOOD SCREENING MARKET SHARE, BY END USER & COUNTRY (2018)
  • 4.3 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD BILLION)
  • 4.4 GEOGRAPHICAL SNAPSHOT OF THE BLOOD SCREENING MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing demand for donated blood and rising number of blood donations
      • 5.2.1.2 Rising prevalence of infectious diseases and emergence of newer pathogens
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Technological advancements
      • 5.2.2.2 Emerging economies
    • 5.2.3 CHALLENGES
      • 5.2.3.1 Need for reducing blood screening prices

6 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
  • 6.2 REAGENTS & KITS
    • 6.2.1 NAT REAGENTS & KITS
      • 6.2.1.1 High sensitivity and rising use of NAT are boosting demand for related reagents and kits
      • 6.2.1.2 Enzymes & polymerases
      • 6.2.1.3 Standards & controls
      • 6.2.1.4 Probes & primers
      • 6.2.1.5 Buffers, nucleotides, & solutions
      • 6.2.1.6 Labeling & detection reagents
    • 6.2.2 ELISA REAGENTS & KITS
      • 6.2.2.1 Ease of use and cost-effectiveness of ELISA reagents & kits will drive market growth
      • 6.2.2.2 Immunosorbents
      • 6.2.2.3 Controls
      • 6.2.2.4 Conjugates
      • 6.2.2.5 Substrates
      • 6.2.2.6 Sample diluents & wash solutions
    • 6.2.3 OTHER REAGENTS & KITS
      • 6.2.3.1 Increasing use of western blot tests and rapid tests will drive the growth of this market segment
  • 6.3 INSTRUMENTS
    • 6.3.1 RENTAL PURCHASE
      • 6.3.1.1 Convenience and cost-effectiveness of renting instruments has resulted in greater end-user preference
    • 6.3.2 OUTRIGHT PURCHASE
      • 6.3.2.1 Availability of government support will increase the outright purchase of instruments
  • 6.4 SOFTWARE & SERVICES
    • 6.4.1 INCREASING ADOPTION OF INSTRUMENTS WILL DRIVE THE DEMAND FOR RELATED SOFTWARE AND SERVICES

7 BLOOD SCREENING MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
  • 7.2 NUCLEIC ACID TESTING
    • 7.2.1 TRANSCRIPTION-MEDIATED AMPLIFICATION
      • 7.2.1.1 High sensitivity of these assays to support market growth
    • 7.2.2 REAL-TIME POLYMERASE CHAIN REACTION
      • 7.2.2.1 Real-time PCR procedures provide more accurate and effective results as compared to conventional PCR
  • 7.3 ENZYME-LINKED IMMUNOSORBENT ASSAY
    • 7.3.1 CHEMILUMINESCENCE IMMUNOASSAY
      • 7.3.1.1 CLIA is ultrasensitive, automated, and a good alternative to conventional methodologies
    • 7.3.2 FLUORESCENT IMMUNOASSAY
      • 7.3.2.1 Rising demand for safer and stable reagents and the development of novel markers to support the growth of this market segment
    • 7.3.3 COLORIMETRIC IMMUNOASSAYS
      • 7.3.3.1 CI offers low sensitivity as it uses vulnerable/limited signal amplification strategies
  • 7.4 RAPID TESTS
    • 7.4.1 RISING AWARENESS ABOUT RAPID TESTS IN EMERGING COUNTRIES TO DRIVE MARKET GROWTH
  • 7.5 WESTERN BLOT ASSAY
    • 7.5.1 GROWING PREVALENCE OF TTIS IN DEVELOPING COUNTRIES HAS RESULTED IN THE INCREASED DEMAND FOR WESTERN BLOT ASSAYS
  • 7.6 NEXT-GENERATION SEQUENCING
    • 7.6.1 NGS IS AN EMERGING TECHNOLOGY IN THE BLOOD SCREENING MARKET

8 BLOOD SCREENING MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 BLOOD BANKS
    • 8.2.1 BLOOD BANKS HOLD THE LARGEST SHARE OF THE BLOOD SCREENING MARKET
  • 8.3 HOSPITALS
    • 8.3.1 INCREASING NUMBER OF SURGICAL PROCEDURES WILL DRIVE THE GROWTH OF THE HOSPITALS SEGMENT

9 BLOOD SCREENING MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 The US dominates the global blood screening market
    • 9.2.2 CANADA
      • 9.2.2.1 Growing volume of surgical procedures performed and high burden of cancer to support market growth
  • 9.3 EUROPE
    • 9.3.1 GERMANY
      • 9.3.1.1 Germany is the largest market for blood screening technologies in Europe
    • 9.3.2 FRANCE
      • 9.3.2.1 Increasing prevalence of HIV to support market growth
    • 9.3.3 UK
      • 9.3.3.1 Government support to prevent transmission of HIV and other infections will drive market growth
    • 9.3.4 ITALY
      • 9.3.4.1 Italy is witnessing an increase in the number of blood donors
    • 9.3.5 SPAIN
      • 9.3.5.1 Increasing adoption of NAT technology will support market growth
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 CHINA
      • 9.4.1.1 China has a high prevalence of infectious diseases
    • 9.4.2 JAPAN
      • 9.4.2.1 Japan has witnessed an increase in the adoption of advanced blood screening technologies
    • 9.4.3 INDIA
      • 9.4.3.1 Increasing number of road accidents will support market growth
    • 9.4.4 AUSTRALIA
      • 9.4.4.1 Rising number of blood donations will propel market growth
    • 9.4.5 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 BRAZIL
      • 9.5.1.1 Increasing incidence of cancer will support the growth of this market
    • 9.5.2 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 RISING PREVALENCE OF INFECTIOUS DISEASES WILL DRIVE MARKET GROWTH IN THE REGION

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 MARKET SHARE ANALYSIS, 2018
    • 10.2.1 MARKET SHARE ANALYSIS FOR NAT BLOOD SCREENING, 2018
    • 10.2.2 MARKET SHARE ANALYSIS FOR TOTAL BLOOD SCREENING, 2018
  • 10.3 COMPETITIVE SCENARIO
    • 10.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017-2019)
    • 10.3.2 PRODUCT LAUNCHES (2017-2019)
    • 10.3.3 EXPANSIONS (2017-2019)
    • 10.3.4 ACQUISITIONS (2017-2019)
  • 10.4 COMPETITIVE LEADERSHIP MAPPING (2019)
    • 10.4.1 VENDOR INCLUSION CRITERIA
    • 10.4.2 VISIONARY LEADERS
    • 10.4.3 INNOVATORS
    • 10.4.4 DYNAMIC DIFFERENTIATORS
    • 10.4.5 EMERGING COMPANIES

11 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)*

  • 11.1 GRIFOLS
  • 11.2 F. HOFFMANN-LA ROCHE
  • 11.3 ABBOTT LABORATORIES
  • 11.4 BIOMERIEUX
  • 11.5 BIO-RAD LABORATORIES
  • 11.6 BECTON, DICKSON AND COMPANY
  • 11.7 DANAHER CORPORATION
  • 11.8 ORTHO CLINICAL DIAGNOSTICS
  • 11.9 SIEMENS HEALTHINEERS
  • 11.10 THERMO FISHER SCIENTIFIC
  • 11.11 DIASORIN
  • 11.12 GE HEALTHCARE
  • 11.13 MERCK KGAA
  • 11.14 PERKINELMER
  • 11.15 BIO-TECHNE
  • 11.16 GFE
  • 11.17 TRINITY BIOTECH
  • 11.18 J. MITRA DIAGNOSTICS PVT. LTD.

Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
Back to Top
전화 문의
F A Q